Literature DB >> 25454294

Chronic liver disease in the human immunodeficiency virus patient.

Chathur Acharya1, Narayan Dharel2, Richard K Sterling3.   

Abstract

There are an estimated 40 million HIV infected individuals worldwide, with chronic liver disease being the 2nd leading cause of mortality in this population. Elevated liver functions are commonly noted in HIV patients and the etiologies are varied. Viral hepatitis B and C, fatty liver and drug induced liver injury are more common. Treatment options for viral hepatitis C are rapidly evolving and are promising, but treatments are limited for the other conditions and is primarily supportive. Opportunistic infections of the liver are now uncommon. Irrespective of etiology, management requires referral to specialized centers and with due diligence mortality can be reduced.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug-induced liver injury; Fatty liver; Hepatitis; Highly active antiretroviral therapy; Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Opportunistic infections

Mesh:

Substances:

Year:  2014        PMID: 25454294     DOI: 10.1016/j.cld.2014.09.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  10 in total

1.  Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.

Authors:  Mandana Khalili; Wendy C King; David E Kleiner; Mamta K Jain; Raymond T Chung; Mark Sulkowski; Mauricio Lisker-Melman; David K Wong; Marc Ghany; Arun Sanyal; Richard K Sterling
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

2.  Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.

Authors:  Raoul Kenfack-Momo; Sebastien Kenmoe; Guy Roussel Takuissu; Jean Thierry Ebogo-Belobo; Cyprien Kengne-Ndé; Donatien Serge Mbaga; Serges Tchatchouang; Martin Gael Oyono; Josiane Kenfack-Zanguim; Robertine Lontuo Fogang; Chris Andre Mbongue Mikangue; Elisabeth Zeuko'o Menkem; Juliette Laure Ndzie Ondigui; Ginette Irma Kame-Ngasse; Jeannette Nina Magoudjou-Pekam; Jean Bosco Taya-Fokou; Arnol Bowo-Ngandji; Seraphine Nkie Esemu; Diane Kamdem Thiomo; Paul Moundipa Fewou; Lucy Ndip; Richard Njouom
Journal:  PLoS One       Date:  2022-05-31       Impact factor: 3.752

3.  Long Noncoding RNAs Hepatocyte Nuclear Factor 4A Antisense RNA 1 and Hepatocyte Nuclear Factor 1A Antisense RNA 1 Are Involved in Ritonavir-Induced Cytotoxicity in Hepatoma Cells.

Authors:  Xiaofei Wang; Yihang Yu; Pei Wang; Kun Yang; Yiting Wang; Liang Yan; Xiao-Bo Zhong; Lirong Zhang
Journal:  Drug Metab Dispos       Date:  2021-12-23       Impact factor: 3.579

4.  Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey.

Authors:  Jeffrey V Lazarus; Kamilla Grønborg Laut; Kelly Safreed-Harmon; Lars Peters; Margaret Johnson; Gerd Fätkenheuer; Irina Khromova; Linos Vandekerckhove; Katarzyna Maciejewska; Roxana Radoi; Anna Lisa Ridolfo; Amanda Mocroft
Journal:  BMC Infect Dis       Date:  2016-07-20       Impact factor: 3.090

5.  Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era.

Authors:  Shannon Wood; Seung Hyun Won; Hsing-Chuan Hsieh; Tahaniyat Lalani; Karl Kronmann; Ryan C Maves; Gregory Utz; Christina Schofield; Rhonda E Colombo; Jason F Okulicz; Jason Blaylock; Brian K Agan; Anuradha Ganesan
Journal:  Open Forum Infect Dis       Date:  2021-02-24       Impact factor: 3.835

Review 6.  Liver involvement in human immunodeficiency virus infection.

Authors:  Pankaj Puri; Sandeep Kumar
Journal:  Indian J Gastroenterol       Date:  2016-06-03

7.  Dissecting the Role of Disturbed ER-Golgi Trafficking in Antivirals and Alcohol Abuse-Induced Pathogenesis of Liver Disorders.

Authors:  Cheng Ji
Journal:  J Drug Abuse       Date:  2017-09-26

8.  Ritonavir and Lopinavir Suppress RCE1 and CAAX Rab Proteins Sensitizing the Liver to Organelle Stress and Injury.

Authors:  Atousa Khalatbari; Pratibha Mishra; Hui Han; Yuxin He; Michelle MacVeigh-Aloni; Cheng Ji
Journal:  Hepatol Commun       Date:  2020-04-08

9.  Prevalence and Factors Associated With Liver Fibrosis Among Adult HIV-Infected Patients Attending Urban and Rural Care Clinics in Uganda.

Authors:  Clara Wekesa; Gregory D Kirk; Jim Aizire; Eve-Marie Benson; Alex Karabarinde; Rosalind Parkes-Ratanshi; Ponsiano Ocama
Journal:  Open Forum Infect Dis       Date:  2020-10-13       Impact factor: 3.835

10.  The Correlated Risk Factors for Severe Liver Damage Among HIV-Positive Inpatients With Abnormal Liver Tests.

Authors:  Sheng Liu; Ying Zhou; Yu Wang; Cheng Bo Li; Wen Wang; Xu Lu; Pei Liu; Qing Hai Hu; Ying Wen
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.